Get started
Author

Alan H. Hartford

Observed names: A. H. Hartford, A.H. Hartford, Alan Hartford, Hartford, Alan, Hartford, Alan H
ORCID: 0000-0001-6369-4028
Observed ORCID: 0000-0001-6369-4028
OpenAlex ID: A5076101013
Simvastatin Does Not Have a Clinically Significant Pharmacokinetic Interaction With Fenofibrate in Humans
2004 · Arthur J. Bergman, Gail Murphy, et al. · The Journal of Clinical Pharmacology · 99
Consequences of misspecifying assumptions in nonlinear mixed effects models
2000 · Alan Hartford, Marie Davidian · Computational Statistics & Data Analysis · 67
Efficacy and safety of CNM-Au8 in amyotrophic lateral sclerosis (RESCUE-ALS study): a phase 2, randomised, double-blind, placebo-controlled trial and open label extension
2023 · Steve Vucic, Parvathi Menon, et al. · EClinicalMedicine · 63
PDF
Geostatistical Methods for Incorporating Auxiliary Information in the Prediction of Spatial Variables
1996 · Carol A. Gotway, Alan H. Hartford · Journal of Agricultural Biological and Environmental Statistics · 52
Pharmacokinetics of Montelukast in Asthmatic Patients 6 to 24 Months Old
2004 · Elizabeth Migoya, Gregory L. Kearns, et al. · The Journal of Clinical Pharmacology · 43
Simulation Practices for Adaptive Trial Designs in Drug and Device Development
2019 · Cristiana Mayer, Inna Perevozskaya, et al. · Statistics in Biopharmaceutical Research · 28
Bayesian detection of potential risk using inference on blinded safety data
2018 · Saurabh Mukhopadhyay, Brian Waterhouse, et al. · Pharmaceutical Statistics · 18
CNM-Au8 in Amyotrophic Lateral Sclerosis
2025 · Douglas Hayden, Po-Ying Lai, et al. · JAMA · 17
Adaptive Designs: Results of 2016 Survey on Perception and Use
2020 · Alan Hartford, Mitchell Thomann, et al. · Therapeutic Innovation & Regulatory Science · 12
The Effect of Etoricoxib on the Pharmacodynamics and Pharmacokinetics of Warfarin
2007 · Jules I. Schwartz, Nancy G. B. Agrawal, et al. · The Journal of Clinical Pharmacology · 12
Using the Bayesian detection of potential risk using inference on blinded safety data (BDRIBS) method to support the decision to refer an event for unblinded evaluation
2021 · Brian Waterhouse, Alan Hartford, et al. · Pharmaceutical Statistics · 10
Adaptive Designs: Results of 2016 Survey on Perception and Use
2018 · Alan Hartford, Mitchell Thomann, et al. · Therapeutic Innovation & Regulatory Science · 10
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning
2019 · Zhan, Tianyu, Hartford, Alan H, et al. · arXiv (Cornell University) · 9
PDF
Dose-ranging design and analysis methods to identify the minimum effective dose (MED)
2017 · Yijie Zhou, Su Chen, et al. · Contemporary Clinical Trials · 9
A Bayesian Approach for PK/PD Modeling with PD Data Below Limit of Quantification
2012 · Huafeng Zhou, Alan Hartford, et al. · Journal of Biopharmaceutical Statistics · 9
A model-based approach for simulating adaptive clinical studies with surrogate endpoints used for interim decision-making
2020 · Xiaotian Chen, Alan Hartford, et al. · Contemporary Clinical Trials Communications · 8
PDF
Bioequivalence of the 4‐mg Oral Granules and Chewable Tablet Formulations of Montelukast
2010 · Barbara Knorr, Alan Hartford, et al. · Archives of Drug Information · 8
Development of a Population Pharmacokinetic Model for Taranabant, a Cannibinoid-1 Receptor Inverse Agonist
2010 · Xiujiang Li, Jace Nielsen, et al. · The AAPS Journal · 6
PDF
A new device design methodology for manufacturability
1998 · J.-C. Lu, W.C. Holton, et al. · IEEE Transactions on Electron Devices · 6
Modified Goldilocks Design with strict type I error control in confirmatory clinical trials
2020 · Tianyu Zhan, Hongtao Zhang, et al. · Journal of Biopharmaceutical Statistics · 3
Pharmacometrics
2019 · Alan H. Hartford, Kenneth G. Kowalski · Springer eBooks · 2
Computational approaches for maximum likelihood estimation for nonlinear mixed models
2000 · Alan Hartford, Marie Davidian, et al. · NCSU Libraries Repository (North Carolina State University Libraries) · 2
PDF
Fitting Compartmental Models to Multiple Dose Pharmacokinetic Data using SAS ® PROC NLMIXED
2009 · Jing Su, Peng Sun, et al. · 1
Optimizing Graphical Procedures for Multiplicity Control in a Confirmatory Clinical Trial via Deep Learning
2020 · Tianyu Zhan, Alan Hartford, et al. · Statistics in Biopharmaceutical Research
Modified Goldilocks Design with strict type I error control in confirmatory clinical trials
2020 · Zhan, Tianyu, Zhang, Hongtao, et al. · Figshare
Works count: 31
Citation count: 494
H-index: 10
I10-index: 12
Year
Topic
Type